Geninus

Founded in 2018 as a spin-off from the Samsung Genome Institute, Geninus is a South Korean genomic analysis company headquartered in Seoul specializing in single-cell sequencing, spatial genomics, and cancer companion diagnostics. The company has developed one of the largest single-cell and spatial transcriptomics databases in Asia and offers the Celinus customized single-cell analysis platform for biomarker discovery and new drug development. Geninus serves biopharmaceutical clients and research institutions with liquid biopsy, RNA biomarker co-development, and precision oncology services, and has pursued international expansion with Japan as a key launchpad for global growth. The company is publicly listed in South Korea.